Glioma cells under hypoxic conditions block the brain microvascular endothelial cell death induced by serum starvation
Authors:
- 25 August 2005
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 95 (1) , 99-110
Abstract
Angiogenesis is one of essential components for the growth of neoplasms, including malignant gliomas. However, tumor vascularization is often poorly organized and marginally functional due to tumor strucutural abnormalities, inducing regional or temporal hypoxic conditions and nutritional shortages in tumor tissues. We investigated how during angiogenesis migrating endothelial cells survive in these hypoxic and reduced nutritional conditions. Human brain microvascular endothelial cells (HBMECs) underwent apoptosis and necrosis after serum withdrawal. This endothelial cell death was blocked by recombinant VEGF protein or the culture medium of U251 glioma cells exposed to hypoxia (H‐CM). Hypoxic treatment increased vascular endothelial growth factor (VEGF) and tumor necrosis factor alpha (TNF‐α) expression in U251 glioma cells. H‐CM activated nuclear factor‐κB (NFκB) protein and increased the gene expression of antiapoptotic factors including Bcl‐2, Bcl‐XL, survivin and X‐chromosome‐linked inhibitor of apoptosis protein (XIAP) in endothelial cells. The survival activity of H‐CM for endothelial cells was abolished by two kinds of VEGF inhibitors {Cyclopeptidic VEGF inhibitor and a VEGF receptor tyrosine kinase inhibitor (4‐[(4′‐chloro‐2′‐fluoro) phenylamino]‐6, 7‐dimethoxyquinazoline)} or NFκB inhibitors (ALLN and BAY 11–7082). These VEGF inhibitors did not block the activation of NFκB induced by H‐CM in endothelial cells. On the contrary, TNF‐α antagonist WP9QY enhanced the survival activity of H‐CM for endothelial cells and blocked NFκB activation induced by H‐CM under serum‐starved conditions. Taken together, our data suggest that both the secretion of VEGF from glioma cells and activation of NFκB in endothelial cells induced by TNF‐α are necessary for endothelial cell survival as they increase the expression of antiapoptotic genes in endothelial cells under conditions of serum starvation. These pathways may be one of the mechanisms by which angiogenesis is maintained in glioma tissues.Keywords
This publication has 52 references indexed in Scilit:
- Cell cycle specific induction of apoptosis and necrosis by paclitaxel in the leukemic U937 cellsLife Sciences, 2005
- Suppression of Vascular Endothelial Growth Factor-Mediated Endothelial Cell Protection by Survivin TargetingThe American Journal of Pathology, 2001
- Marked Induction of the IAP Family Antiapoptotic Proteins Survivin and XIAP by VEGF in Vascular Endothelial CellsBiochemical and Biophysical Research Communications, 1999
- NF-κB Activation Is Required for Human Endothelial Survival during Exposure to Tumor Necrosis Factor-α but Not to Interleukin-1β or LipopolysaccharideJournal of Biological Chemistry, 1999
- The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappa B that blocks TNFalpha -induced apoptosisGenes & Development, 1999
- Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-κBJournal of Clinical Investigation, 1999
- Novel Inhibitors of Cytokine-induced IκBα Phosphorylation and Endothelial Cell Adhesion Molecule Expression Show Anti-inflammatory Effects in VivoJournal of Biological Chemistry, 1997
- Possible Participation of Autocrine and Paracrine Vascular Endothelial Growth Factors in Hypoxia-induced Proliferation of Endothelial Cells and PericytesJournal of Biological Chemistry, 1995
- Morphological Change and Destabilization of β-Actin mRNA by Tumor Necrosis Factor in Human Microvascular Endothelial CellsExperimental Cell Research, 1993
- Tumor necrosis factor inhibits the proliferation of cultured capillary endothelial cellsBiochemical and Biophysical Research Communications, 1987